جستجوی استاد راهنمای دانشگاهی

Joel Goh is Associate Professor at the Department of Analytics and Operations, NUS Business School, National University of Singapore. He serves as Director of the J.Y. Pillay Comparative Asia Research Centre (under NUS Global Asia Institute) and PhD Program Director at the Institute of Operations Research and Analytics (IORA). Previously, he was Assistant Professor at Harvard Business School (2014-2017) and Visiting Scholar (2017-2022). BSc, MSc, PhD in Operations, Information, and Technology from Stanford University His research focuses on healthcare analytics (preventing health conditions, hospital operations, frailty assessment), supply chain analytics (digital business models, platform leakage), and service platform operations (hospital-at-home programs, incentive design). He co-created the Robust Optimization Made Easy (ROME) software. Recent publications analyze workplace psychological safety (2024), hospital-at-home models (2024), and platform leakage dynamics (2023). His work spans 18+ journals with 740+ citations for burnout cost studies (2022) and 606+ citations for physician well-being research (2017). Teaching Honors : 2023: Best MBA Teaching & Skinner Innovation Award 2021: NUS Annual Teaching Excellence Award 2020: Early Career Research Excellence Award & 40 Under 40 Best MBA Professors Advising & Grants : Served as PhD Program Director. Received NUS Start-Up Grant R-314-000-110-133 (2021) and Humanities & Social Sciences Fellowship (2021). Editorial roles include Associate Editor at Management Science , Manufacturing & Service Operations Management , and Senior Editor at Production and Operations Management .

• Health services and systems
• Transportation, logistics and supply chains
• Operations research
• +۶ مورد دیگر

Dr. Daniel Dutton is an Associate Professor in the Department of Community Health and Epidemiology at Dalhousie University's Faculty of Medicine, based at the Dalhousie Medicine New Brunswick campus in Saint John. His research focuses on how social environments influence health outcomes and the role of government policies in mitigating these impacts, particularly in areas like poverty, homelessness, and health economics. He holds adjunct roles at the University of New Brunswick (Sociology) and is the Scientific Director of APPTA, a hub bridging aging research and policy. He teaches courses in epidemiology, population health, and statistics. Education: PhD in Community Health Sciences (University of Calgary) MA in Economics (University of Calgary) BA Honours in Economics (Queen’s University) Research Interests: Dr. Dutton examines population-level health determinants, government policy effectiveness, and socioeconomic disparities. His work employs large datasets and econometric models to analyze topics such as homelessness incidence, healthcare cost savings through preventive measures, and the distributional impacts of public spending. Key Contributions: Scientific Director of the APPTA aging and technology hub. Co-founder of the IMPART research collaborative. Author of influential studies on Housing First programs, opioid prescribing patterns, and the fiscal benefits of guaranteed annual income policies. Advising & Grants: Supervises multiple MSc students and has collaborated on grants analyzing healthcare utilization in New Brunswick and Alberta. His work often intersects with policy-making, emphasizing actionable insights from quantitative research. Labs & Teams: Leads the Dutton Research Group, which uses mascot Odin the Saint Bernard to foster team cohesion. Active in interdisciplinary collaborations across public health, sociology, and economics.

• Social Epidemiology
• Public Health Policy
• Health Economics
• +۳ مورد دیگر

Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.

• Microbial Genomics
• Gut Microbiome
• Aging and Healthy Aging
• +۴ مورد دیگر

Rong Zheng is a Professor in the Department of Computing and Software and a member of the School of Biomedical Engineering at McMaster University, Canada. She holds a Tier-1 Canada Research Chair in Mobile Computing and serves as Acting Chair of the Computing and Software department from July to December 2025. She is also an Associate Member of the Electrical & Computer Engineering department. Education: Ph.D. in Computer Science, University of Illinois, Urbana-Champaign, USA Master of Engineering (thesis) in Electrical Engineering, Tsinghua University, Beijing, China Bachelor of Engineering in Electrical Engineering, Tsinghua University, Beijing, China Dr. Zheng's research lies at the intersection of mobile computing, wireless networking, and machine learning, with a strong focus on applications for aging populations. She directs the NSERC Smart Mobility for the Aging Population CREATE program. Her work encompasses sensor development, wireless network design, and mobile data analytics to address real-world challenges in healthcare, mobility, and data center monitoring. She has developed innovative solutions like the MacQuest campus navigation app and has captured first prize in indoor localization competitions. Her recent publications demonstrate a clear trajectory toward applying wireless sensing technologies (particularly acoustic, Wi-Fi, and mmWave) to health monitoring and mobility assessment for older adults. There's a strong emphasis on developing efficient edge computing solutions that can process data in real-time on resource-constrained devices, as exemplified by her TeamNet framework for collaborative inference on the edge. Her work bridges theoretical advances with practical applications that have social impact. Scientific Awards: Tier-1 Canada Research Chair in Mobile Computing US National Science Foundation CAREER Award (2006) Joseph Ip Distinguished Engineering Fellow (2015-2018) Dr. Zheng leads the Wireless System Research Group (WiSeR) at McMaster University, which has secured significant funding including a $1.65M NSERC CREATE grant for smart mobility research for older adults. Her research has been supported by multiple funding agencies including NSERC, NSF, UH GEAR, and DURIP. She actively mentors graduate students and has developed specialized courses including CAS 772 (Mobile Data Analytics) and CAS 781 (Mobility in the Aging Population). The WiSeR group conducts impactful research on communication, networking, and data analytics issues in Cyber Physical Systems, with applications spanning healthcare, smart infrastructure, and data center monitoring. Their work on data center infrastructure monitoring networks has been featured in EurekAlert and Data Center Dynamics, and they've made significant contributions to indoor localization technology.

• Mobile computing
• Wireless networking
• Cyber physical systems
• +۴ مورد دیگر

Professor Simon Fraser is a public health physician and academic at the University of Southampton , specializing in kidney disease and multimorbidity. His work integrates epidemiology, health literacy, and inequality analysis to address chronic disease burdens. Educational Background: BM (University of Southampton, 1992) MSc in Public Health DM (Doctor of Medicine, 2014) Research Focus: Fraser's research spans kidney disease , multimorbidity , treatment burden , and health inequalities . Recent projects include the NURTuRE-CKD HRQoL Study and MELD-B , examining determinants of chronic disease progression and intervention design. Academic Contributions: His publications from 2024-2025 emphasize electronic health records for multimorbidity analysis, neonatal risk factors for adult comorbidity, and deprescribing strategies for older adults. Collaborations include NIHR Applied Research Collaboration Wessex and Kidney Research UK. Scientific Recognition: Fellow of the Faculty of Public Health (FFPH) Member of the Royal College of General Practitioners (MRCGP) Fellow of the Higher Education Academy (FHEA) Mentorship: Current PhD students include Emilia Mary Holland and Keegan Guan Ru Lee . He co-leads projects with leading researchers in public health and nephrology.

• Healthcare
• Public Health
• Kidney Disease
• +۳ مورد دیگر

Dr. Michael Wilczek is Assistant Teaching Professor in Biotechnology/Bioinformatics at Northeastern University's Roux Institute. His research bridges virology, bioinformatics, and educational innovation, with particular focus on JC polyomavirus pathogenesis and graduate education reform. Key research domains include: Molecular mechanisms of viral infections Bioinformatic analysis of host-pathogen interactions Observational health and real-world evidence Evidence-based graduate education His publication record demonstrates: Expertise in JC polyomavirus cellular pathways Innovative applications of machine learning in virology High-throughput drug screening methodologies Health disparities research in aging populations

• Virology
• Bioinformatics
• Molecular Epidemiology
• +۳ مورد دیگر

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +۷ مورد دیگر

Ryan M Hebert, MD, is an Assistant Professor of Neurosurgery at the Yale School of Medicine, affiliated with the Neurosurgery department. He specializes in neurovascular disorders, including open and endovascular treatments for intracranial aneurysms, arteriovenous malformations, carotid disease, and dural arteriovenous fistulas. He also focuses on interventions for ischemic and hemorrhagic strokes. His practice locations include Yale New Haven Hospital and Lawrence and Memorial Hospitals in Connecticut. Education & Training: Bachelor’s in Molecular, Cellular, and Developmental Biology from the University of Colorado – Boulder (Howard Hughes Undergraduate Research Grant recipient) MD from Yale School of Medicine (NIH-funded thesis on CCM3 in cerebral cavernous malformations) 7-year Neurosurgery Residency at Yale New Haven Hospital, including enfolded neuro-interventional training CAST-accredited fellowship in Endovascular Neurosurgery and Neurovascular Critical Care at Thomas Jefferson University Hospital (2016) Research Interests: Dr. Hebert’s work centers on emerging surgical and endovascular techniques for neurovascular disorders, risk stratification in carotid disease, vasospasm prediction/post-subarachnoid hemorrhage treatment, and outcomes of minimally invasive spine surgery. His studies often integrate clinical practice with translational research, emphasizing patient outcomes and procedural optimization. Key topics include flow diverters, cranial nerve palsies, hospital frailty risk scores, and immune mechanisms driving aneurysm rupture. Publications Trends: His recent articles emphasize clinical outcomes of endovascular procedures, stroke interventions, and immune mechanisms in aneurysm rupture. He frequently collaborates on meta-analyses and systematic reviews to evaluate treatment efficacy and complication rates, particularly involving cranial nerve recovery and thrombectomy volumes. Awards & Grants: He secured an NIH-funded thesis and a Howard Hughes Undergraduate research grant. No explicit scientific awards are listed, but his work has been recognized via peer-reviewed publications and contributions to clinical guidelines. Advising & Grants: While no students are listed, he collaborates with prominent researchers like Charles Matouk, Kevin Sheth, and Joseph Antonios on NIH-funded projects. His research addresses healthcare resource utilization and procedural volume impacts on mortality, indicating a focus on translational and clinical studies. Labs & Teams: Active in interdisciplinary teams at Yale School of Medicine, particularly in neurovascular critical care and endovascular surgery. Collaborates with the Stroke Center and Janeway Society for physician-scientist development.

• Neurovascular Surgery
• Cerebrovascular Disorders
• Stroke Intervention
• +۳ مورد دیگر

Janani Thillainadesan is an NHMRC Senior Research Fellow at the Sydney Medical School/Concord Clinical School and the Centre for Education and Research on Ageing, affiliated with the Faculty of Medicine and Health at the University of Sydney. She is also a member of the Charles Perkins Centre. Her research focuses on optimizing healthcare delivery for older adults, particularly in geriatric surgery, perioperative care, and dementia interventions. Key research areas include frailty assessment, deprescribing strategies, collaborative care models, and leveraging technology (e.g., mobile health) in geriatric medicine. She has contributed to multidisciplinary studies involving clinical datasets, quality indicators, and mixed-methods analyses of patient experiences and care expectations. Awards: 2023 RACP Vincent Fairfax Research Fellowship 2021 ANZSGM Career Investigator Prize 2021 UK Age Anaesthesia Association Best Oral Presentation Prize 2019 Evidence Based Perioperative Medicine Asia Congress Runner Up Prize Her work bridges clinical practice, education, and policy through grants like the 2024 electronic frailty index project. Media engagement includes a 2019 Studio 10 segment highlighting her contributions to aging-related healthcare innovations.

• Health services for older people
• Collaborative models of care
• Frailty
• +۴ مورد دیگر

Katherine Ornstein is a Professor at the Johns Hopkins School of Nursing with joint appointments in the Bloomberg School of Public Health's Department of Health Policy and Management, and the School of Medicine's Division of Geriatric Medicine and Gerontology. She directs the Center for Equity in Aging and is affiliated with multiple JHU aging-related centers. Her work focuses on improving healthcare equity for older adults with serious illness, home-based care delivery, dementia care, and end-of-life care. She holds a PhD in epidemiology from Columbia University. Her research, funded by NIH and CDC, explores caregiving burdens, homebound populations, and the economic impacts of healthcare on families. Notable recent work includes studies on dementia care outcomes, social isolation's health effects, and pandemic impacts on homebound older adults. Education: PhD in Epidemiology (Columbia University), MPH, BA Dr. Ornstein's awards include the 2024 Excellence in Research Mentoring and 2023 Isabel Hampton Robb Distinguished Scholar. She has advised numerous NIH-funded studies and collaborates across disciplines to address healthcare disparities in aging populations. Current projects examine rural-urban disparities in palliative care access, caregiver mental health, and leveraging big data to improve home-based care models. She leads efforts to define criteria for effective home-based primary care and reduce inequities in dementia care delivery.

• Aging
• Dementia
• Healthcare Equity
• +۵ مورد دیگر

Dr. Kenji Fujita is a Research Fellow at the Kolling Institute, University of Sydney, specializing in ageing, pharmacology, and pharmaceutical care quality. He holds a PhD, MScMed (ClinEpid), and BPharm from the University of Sydney. Previously a pharmacist in Japan, he leads international initiatives in the Pharmaceutical Care Network Europe (PCNE) and the International Pharmaceutical Federation (FIP). His work focuses on deprescribing strategies, polypharmacy, and developing quality indicators for healthcare services. Dr. Fujita’s research integrates big data analysis, statistical modeling, and machine learning to address challenges in geriatric pharmacotherapy. Current projects include validating frailty indices, evaluating deprescribing interventions in older adults, and developing NLP tools for clinical documentation analysis. He has also contributed to assessing organizational readiness for guideline implementation in community pharmacies. Awards include the 2023 Outstanding Poster Presentation Award at the IAGG Asia/Oceania Congress and 2022 Best Poster at the Japanese Society of Social Pharmacy. He has secured grants such as the 2024 electronic frailty index project and the 2021 systems-approach to medication review initiative. Dr. Fujita collaborates with global networks like J-HOP (Japan Home Visiting Pharmacy Association) and leads multidisciplinary teams across Australia and Europe. His lab focuses on translating data-driven insights into actionable clinical practices to improve medication safety and quality in ageing populations.

• Healthy Ageing
• Pharmacology
• Pharmacoepidemiology
• +۳ مورد دیگر

Professor David Alldred is a Professor of Medicines Use and Safety at the University of Leeds' School of Healthcare, within the Faculty of Medicine and Health. His expertise spans medicines optimisation, patient safety, deprescribing, and care home medication management. He leads key research initiatives such as the NIHR Yorkshire and Humber Patient Safety Research Collaboration's 'Decluttering Safely for Safety' theme and co-leads the School of Healthcare's Quality and Safety research theme. Education: PhD (clinical research on care home medication review), MSc in Clinical Pharmacy, PGCert in Learning and Teaching, and BPharm (Hons). Professional memberships include Fellowships of the Royal Pharmaceutical Society and the Higher Education Academy. Research focuses on improving medication use for older adults in care homes and underserved populations, employing systematic reviews, qualitative studies, and RCTs. Notable projects include the CHUMS study (Department of Health-funded medication error analysis in care homes) and leadership roles in NIHR Programme Grants like CHIPPS and CHARMER. He collaborates with NHS England to implement medicines optimisation programs and co-designed multilingual medication review resources to reduce health inequalities. Awards include the Pharmacy Practice UK Research Award (2015) and NIHR Senior Investigator status (2025). His work emphasizes translating evidence into clinical practice, with over 150 publications and supervising NIHR-funded doctoral students in critical care, diabetes, cystic fibrosis, and geriatrics. Led the Care Homes' Use of Medicines Study (CHUMS), contributed to NICE guidelines for care home medicines management, and developed interventions like the Medicines at Transitions Intervention (MaTI) for heart failure patients. His research themes address polypharmacy reduction, medication safety across care transitions, and pharmacist-led deprescribing strategies.

• Medicines Optimisation
• Patient Safety
• Deprescribing
• +۵ مورد دیگر

Nashwa Masnoon is a Postdoctoral Research Fellow in Geriatric Pharmacotherapy at the Kolling Institute, part of the Faculty of Medicine and Health at the University of Sydney. She is also a hospital pharmacist at the Royal North Shore Hospital. Her academic background includes a BPharm(Hons) and a PhD from the University of South Australia, where her doctoral work focused on identifying risks of adverse outcomes from polypharmacy in older adults with multimorbidity. Dr Masnoon’s research interests span geriatric pharmacology, deprescribing practices, pharmacoepidemiology, and quality use of medicines. Her current projects include developing stewardship programs for anticholinergic/sedative deprescribing, optimizing medication use in hospitals for older patients, and educating hospital pharmacists using the Drug Burden Index intervention bundle. She has co-supervised Honours students in 2022 and 2023, focusing on deprescribing in hospital settings and patient-reported experiences post-intervention. Research Themes: Healthy Ageing Key Approaches: Systematic reviews, clinical interventions, pharmacoepidemiological analysis Dr Masnoon has received notable awards including the 2023 FMH Showcase Travel Award, Royal North Shore Hospital Travel Fellowship (2023), and a 2017 People’s Choice Award for her 3 Minute Thesis presentation. Her work emphasizes improving medication outcomes through evidence-based deprescribing and precision medicine approaches. She is affiliated with the Australasian Pharmaceutical Science Association (APSA), International Pharmaceutical Federation (FIP), and Australian Deprescribing Network (ADeN). Her grants include the 2024 electronic frailty index project and a 2022 travel award-funded initiative.

• Geriatric Pharmacology
• Deprescribing
• Pharmacoepidemiology
• +۳ مورد دیگر

Professor Joy Ho is a Clinical Professor of Medicine at the University of Sydney’s Central Clinical School and a Senior Staff Specialist in Haematology at Royal Prince Alfred Hospital (RPAH). She serves as Director of Research and Head of the Multiple Myeloma Research Unit and Thalassemia/Haemoglobinopathy Unit at the Institute of Haematology, RPAH. Her research focuses on multiple myeloma, lymphoma, thalassemia, and iron metabolism, with a strong emphasis on clinical trials and translational medicine. She has led numerous multi-centre trials, including pioneering studies on CAR-T cell therapy for lymphoma and novel therapies for myeloma. Prof Ho’s education includes MB.BS. (Hons) from Sydney, D.Phil (Oxford), and fellowships from the Royal Australasian College of Physicians (RACP) and Royal College of Pathologists of Australasia (RCPA). She has held leadership roles in major hematology organizations, including the International Myeloma Working Group (IMWG) and the American Society of Hematology (ASH). Her international collaborations span Singapore, Thailand, and the United States. Her research interests include: Multiple Myeloma: Developing therapies targeting tumor microenvironment and immune modulation. Lymphoma: Pioneering CAR-T cell therapy in Australia. Thalassemia: Gene therapy and iron chelation advancements, including the landmark Northstar trial. Iron Metabolism: Investigating hepcidin and its role in transfusion-dependent anemias. Her recent publications highlight breakthroughs in CAR-T efficacy, myeloma biomarkers, and thalassemia management. Awards include the 2019 Sydney Local Health District Clinical Trial Award and election to the International Myeloma Society Board. She has secured over $2 million in grants for cutting-edge equipment and research. Prof Ho’s academic contributions extend to teaching and supervision, training fellows for RACP/RCPA certifications. Her leadership in national registries (e.g., Australian Haemoglobinopathy Registry) and guidelines (e.g., iron chelation protocols) underscores her commitment to advancing hematology care globally.

• Multiple Myeloma
• Lymphoma
• Thalassemia
• +۵ مورد دیگر

Fabio Sigrist is a Professor of Applied Statistics and Data Science at the Institute of Financial Services Zug (IFZ) , part of the Lucerne University of Applied Sciences and Arts . He also holds a Senior Scientist and Lecturer position at the Seminar for Statistics, ETH Zurich . His career spans academic research, industry consulting, and project leadership in finance and data science. PhD in Statistics (2013), ETH Zurich MSc in Mathematics with distinction (2008), ETH Zurich MEd in Mathematics Education (2008), ETH Zurich Sigrist’s research focuses on integrating Machine Learning with Spatial Statistics for applications in Financial Econometrics and Credit Risk . His work includes developing novel algorithms like GPBoost and KTBoost , advancing spatio-temporal modeling , and applying tree-based boosting to financial problems. Projects such as CreHos (credit risk in hospitality) and NISMO (interpretable real estate modeling) highlight his interdisciplinary approach. His publications address challenges in large-scale spatial data , loss given default modeling , and stock volatility prediction . He contributes to software development with tools like spate (R package) and varycoef (spatially varying coefficients).

• Machine Learning
• Spatial Statistics
• Financial Econometrics
• +۳ مورد دیگر